Corcept Therapeutics (CORT) Announces 11M Common Offering

Corcept Therapeutics Incorporated (Nasdaq: CORT), is offering to issue and sell 11,000,000 shares of its common stock in an underwritten public offering. Credit Suisse Securities (USA) LLC is acting as sole book-running manager and underwriter in the offering. The last reported sale price of its common stock on June 29, 2012 was $4.49 per share. Corcept also intends to grant the underwriter a 30 day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
• CleanTech Vanadium plans $1M private placement at $0.10 per unit
• Nebius Group prices upsized $5B convertible notes offering